MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

EXACT Sciences Company Profile (NASDAQ:EXAS)

Consensus Ratings for EXACT Sciences (NASDAQ:EXAS) (?)
Ratings Breakdown: 7 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $10.33 (15.65% downside)

Analysts' Ratings History for EXACT Sciences (NASDAQ:EXAS)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Craig HallumReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Robert W. BairdReiterated RatingOutperform$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Roth CapitalReiterated RatingHold$7.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Jefferies GroupReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Canaccord GenuityReiterated RatingBuy$9.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016MizuhoReiterated RatingHold$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Goldman SachsLower Price TargetNeutral$8.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016StephensDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Benchmark Co.Reiterated RatingHold$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Lake Street CapitalReiterated RatingHold$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015WedbushLower Price Target$7.00 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015JMP SecuritiesBoost Price TargetOutperform$27.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Maxim GroupBoost Price TargetSell$8.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for EXACT Sciences (NASDAQ:EXAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/18/2016        
5/3/2016Q116($0.52)($0.49)$15.17 million$14.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q415($0.47)($0.41)$14.96 million$14.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($0.44)($0.45)$12.56 million$12.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2015Q215($0.45)($0.44)$7.96 million$8.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q115($0.41)($0.40)$4.11 million$4.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.04)($0.38)$19.90 million$1.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314($0.32)($0.39)$0.13 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2014Q214($0.25)($0.24)$0.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.19)($0.23)$0.40 million$0.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014Q413($0.19)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.18)($0.16)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2013Q2 2013($0.18)($0.19)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013($0.20)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2013Q4 2012($0.18)($0.22)$1.04 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012Q312($0.21)($0.21)$1.03 million$1.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012($0.20)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.18)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.15)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.10)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.09)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.08)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for EXACT Sciences (NASDAQ:EXAS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.54)($0.46)($0.51)
Q2 20164($0.56)($0.54)($0.55)
Q3 20164($0.55)($0.47)($0.52)
Q4 20164($0.55)($0.40)($0.50)
Q1 20172($0.44)($0.35)($0.40)
Q2 20172($0.42)($0.34)($0.38)
Q3 20172($0.40)($0.35)($0.38)
Q4 20172($0.38)($0.36)($0.37)
(Data provided by Zacks Investment Research)
Dividend History for EXACT Sciences (NASDAQ:EXAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for EXACT Sciences (NASDAQ:EXAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/1/2016D Scott CowardSVPSell1,685$6.62$11,154.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016D Scott CowardSVPSell2,175$6.05$13,158.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Graham Peter LidgardInsiderSell3,041$6.05$18,398.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Maneesh AroraCOOSell4,042$6.05$24,454.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016James Edward DoyleDirectorBuy5,000$6.43$32,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Katherine S NapierDirectorBuy3,775$5.38$20,309.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Kevin T ConroyCEOBuy50,000$5.00$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Kevin T ConroyCEOSell6,895$5.81$40,059.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Graham Peter LidgardInsiderSell2,997$5.52$16,543.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Maneesh AroraCOOSell4,099$5.52$22,626.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Graham Peter LidgardInsiderSell2,411$6.39$15,406.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Kevin T ConroyCEOSell6,866$6.39$43,873.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Maneesh AroraCOOSell2,556$6.39$16,332.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016David ThompsonDirectorBuy15,000$6.99$104,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Graham Peter LidgardDirectorSell3,938$23.44$92,306.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Kevin T ConroyCEOSell8,425$23.44$197,482.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Maneesh AroraCOOSell3,895$23.44$91,298.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Graham Peter LidgardDirectorSell4,037$22.90$92,447.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Kevin T ConroyCEOSell9,798$22.90$224,374.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Maneesh AroraCOOSell2,995$22.90$68,585.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Graham Peter LidgardInsiderSell3,363$26.72$89,859.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Kevin T ConroyCEOSell9,484$26.72$253,412.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Maneesh AroraCOOSell2,495$26.72$66,666.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Graham Peter LidgardInsiderSell8,015$24.68$197,810.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Graham Peter LidgardVPSell11,081$15.99$177,185.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Kevin T ConroyCEOSell11,336$15.99$181,262.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Maneesh AroraCOOSell9,291$15.99$148,563.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014William MeganSVPBuy10,000$11.79$117,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Graham Peter LidgardVPSell3,160$14.07$44,461.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Kevin ConroyCEOSell8,708$14.07$122,521.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Maneesh AroraCOOSell2,662$14.07$37,454.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Graham Peter LidgardVPSell10,288$11.96$123,044.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Kevin ConroyCEOSell26,379$11.96$315,492.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Maneesh AroraCOOSell8,627$11.96$103,178.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Graham Peter LidgardVPSell7,430$11.07$82,250.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Sally CrawfordDirectorSell25,000$12.19$304,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012Kevin T ConroyCEOBuy2,000$9.13$18,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012Maneesh AroraCFOBuy1,000$9.04$9,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Lionel SterlingDirectorBuy5,500$9.08$49,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for EXACT Sciences (NASDAQ:EXAS)
DateHeadline
07/01/16 06:16 AMSizzling News: Shire plc (NASDAQ:SHPG), Exact Sciences Corporation (NASDAQ:EXAS) - Money News (press release)
06/30/16 04:13 PMEXACT Sciences Corporation (NASDAQ:EXAS): believe Or Not, that’s how we Made 55% Profit In Just 2-Week
06/29/16 03:53 PMAnalyst Rating Update on EXACT Sciences Corporation (EXAS) - Trade Calls
06/29/16 06:16 AMTake a look at Analysts Tips: EXACT Sciences Corporation (NASDAQ:EXAS) , CTI BioPharma Corp. (NASDAQ:CTIC) - Street Updates
06/29/16 05:00 AMExact Sciences to host second-quarter 2016 results, annual meeting webcasts and calls - [PR Newswire] - MADISON, Wis., June 29, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2016 financial results ...
06/28/16 03:54 PMCovering the Bases on EXACT Sciences Corporation (NASDAQ:EXAS): Where is the Stock Going? - Press Telegraph
06/28/16 03:54 PMFocus Stock Recap for: EXACT Sciences Corporation (NASDAQ:EXAS) - Telanagana Press
06/28/16 03:54 PMCurrent Analysts Rating Update: EXACT Sciences Corporation (NASDAQ:EXAS) , Envision Healthcare Holdings, Inc ... - Street Updates
06/27/16 03:52 PMActive Company Share Review : Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
06/27/16 08:25 AMEXACT Sciences Corporation (EXAS) Updated Price Targets - FTSE News
06/25/16 07:48 AMExact Sciences Corporation (EXAS) Jumps 7.15% on June 23 - Equities.com
06/24/16 04:00 PMAnalysts watching two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS) , Anthem, Inc. (NYSE:ANTM) - Street Updates
06/23/16 10:30 AMBiotech Stock Bounce Picks Up Momentum -
06/23/16 05:10 AMExact Sciences Corporation (NASDAQ:EXAS) missed earnings on 4 occasions
06/23/16 05:10 AMEXACT Sciences Corporation (NASDAQ:EXAS) PEG Ratio Is
06/22/16 09:08 PMAnalyst Review on this Stock: Exact Sciences Corporation (NASDAQ:EXAS)
06/21/16 12:56 PMExact Sciences: What If Its Price Target is Raised and No One Notices? -
06/21/16 08:35 AMTwo Movers within Analysts Observation: EXACT Sciences Corporation (NASDAQ:EXAS) , Envision Healthcare ... - Street Updates
06/21/16 08:35 AMCurrent Analysts Rating Update: EXACT Sciences Corporation (NASDAQ:EXAS) , Celgene Corporation (NASDAQ ... - Street Updates
06/20/16 03:48 PMAnalyst’s Keeping an Eye on EXACT Sciences Corporation (NASDAQ:EXAS)
06/20/16 01:25 PMETF’s with exposure to EXACT Sciences Corp. : June 20, 2016 -
06/18/16 08:27 AMEXACT Sciences Corporation (NASDAQ:EXAS) Shares Recover After Colonguard Launch
06/18/16 08:27 AMUpgrades And Downgrades For EXACT Sciences Corporation (EXAS)
06/17/16 03:45 PMThe Key Numbers To Watch From Exact Sciences Corporation (NASDAQ:EXAS)’s Earnings
06/17/16 08:41 AMThe Big News That's Creating Excitement in This Tiny Stock -
06/17/16 06:34 AMEarnings Stocks Analysis: Exact Sciences Corporation (NASDAQ:EXAS), Cigna Corp. (NYSE:CI) - Beacon Chronicle
06/16/16 09:09 PMNew Highs at Close – QBAK, AVNW, PULM, EXAS, CAPR, ITUS, QLGC
06/16/16 09:09 PMThe Reason For EXACT Sciences Corporation (NASDAQ:EXAS) Stock Price Jump
06/16/16 09:09 PMEXACT Sciences Corporation (NASDAQ:EXAS) Estimated To Achieve An EPS Of $
06/16/16 09:09 PMChart Power: EXACT Sciences Corporation (NASDAQ:EXAS), Direxion Shares Exchange Traded Fund Trust(NYSEARCA:DUST)
06/16/16 09:09 PMEye Catching Stock: Exact Sciences Corporation (NASDAQ:EXAS)
06/16/16 03:57 PMStocks to Watch: Vical Incorporated (NASDAQ:VICL), Exact Sciences Corporation (NASDAQ:EXAS), Ford Motor ... - KC Register
06/16/16 03:57 PMBiotech Beat: All Eyes On Relypsa Inc (RLYP) And EXACT Sciences Corporation (EXAS) - Smarter Analyst
06/16/16 07:59 AMMorning Movers: Exact Sciences Jumps on Upgrade, Devon Energy Gains on Asset Sale -
06/15/16 04:00 PMThe Market In 5 Minutes: Janet Yellen, Exact Sciences, grad advice - Detroit Free Press
06/15/16 04:00 PMHC Stocks Zone: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
06/15/16 04:00 PMEarnings Analysis to see: Exact Sciences Corporation (NASDAQ:EXAS), Micron Technology, Inc. (NASDAQ:MU) - Beacon Chronicle
06/15/16 04:00 PMNoteworthy Analysts Suggestions: EXACT Sciences Corporation (NASDAQ:EXAS) , Novo Nordisk A/S (NYSE:NVO) - Street Updates
06/15/16 02:50 PMExact Sciences: Yes, There Was a Leak -
06/15/16 09:49 AMUpdated colorectal cancer screening guidelines bullish for EXACT Sciences; shares up again today -
06/15/16 08:40 AMEXACT Sciences Corporation (NASDAQ:EXAS): In Just 24 Hours, The Stock Jumps 45% From Our Alert Price
06/15/16 08:40 AMEXACT Sciences Corporation (EXAS) Stock Hikes More Than 50% , Reasons Unexplained
06/15/16 08:26 AMExact Sciences Stock Rebounds On Leaked Testing Guidelines -
06/14/16 03:50 PMWhy Exact Sciences Stock Is Soaring 33% Today - Motley Fool
06/14/16 03:42 PMWhy Exact Sciences Stock Is Soaring 33% Today -
06/13/16 05:29 AMCollegium Announces Election of John A. Fallon, M.D. to Board of Directors - [at noodls] - CANTON, Mass., June 13, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the election of John A. Fallon, M.D. to the Board of Directors. ... This is an abstract of ...
06/11/16 06:47 AMAnalyst Rating Fluctuations to Observe: EXACT Sciences Corporation (NASDAQ:EXAS) , Amarin Corporation PLC ... - Street Updates
06/07/16 09:38 PMExact Sciences Corporation (EXAS) Jumps 7.84% on June 06 - Equities.com
06/07/16 04:02 PMEarnings Expectations Overview: BankUnited, Inc. (NYSE:BKU), Exact Sciences Corporation (NASDAQ:EXAS) - Beacon Chronicle
06/06/16 03:48 PMAnalyst Overview on These 2 Stocks: Exact Sciences Corporation (NASDAQ:EXAS), Neothetics, Inc. (NASDAQ:NEOT) - Beacon Chronicle
About EXACT Sciences

EXACT Sciences logoExact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: EXAS
  • CUSIP: 30063P10
Key Metrics:
  • Previous Close: $11.29
  • 50 Day Moving Average: $7.99
  • 200 Day Moving Average: $7.18
  • P/E Ratio: N/A
  • P/E Growth: -0.25
  • Market Cap: $1.20B
  • Current Quarter EPS Consensus Estimate: $-2.00 EPS
Additional Links:
EXACT Sciences (NASDAQ:EXAS) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha